G9205 HCPCS Level II code: Patient starting antiviral treatmentfor hepatitis c during the measurement period

CMS terminated G9205: its last date of service was Dec 31, 2016. It stays here for looking up older claims; newer services need a current code.

Official description

G9205

Patient starting antiviral treatmentfor hepatitis c during the measurement period

Short description: Hep c antiviral started

HCPCS · United States

Medicare details

The indicators CMS publishes with G9205 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Carrier judgment
Medicare pricing
Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
Type of service
Medical care
BETOS category
Specialist - psychiatry
Added
Jan 1, 2014
Terminated after
Dec 31, 2016

Where G9205 sits

  1. 1G codesProcedures and professional services
  2. 2Terminated G9205Patient starting antiviral treatmentfor hepatitis c during the measurement period

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

Is HCPCS code G9205 still valid?

No. CMS terminated G9205; its last date of service was Dec 31, 2016. It is listed for looking up services from before then. Use a current code for newer services.

Does Medicare cover G9205?

CMS lists G9205’s Medicare coverage as “Carrier judgment” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.

G9199Venous thromboembolism (vte) prophylaxis not administered the day of or the day after hospital admission for documented reasons (eg, patient is ambulatory, patient expired during…G9200Venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not givenG9201Venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admissionG9202Patients with a positive hepatitis c antibody testG9203Rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis cG9204Rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not givenG9206Patient starting antiviral treatment for hepatitis c during the measurement periodG9207Hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis cG9208Hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not givenG9209Hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatmentG9210Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g., patients whose treatment was…G9211Hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given